Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: To compare the clinical and radiographic results of three approaches-involving particulate bone graft, recombinant human bone morphogenetic protein-2 (rhBMP-2)+absorbable collagen sponge (ACS), and no graft material-for lateral maxillary sinus augmentation with simultaneous dental implant placement.

Materials And Methods: From January 2015 to June 2021, a retrospective analysis was performed on 63 patients (a total of 122 implants) who underwent lateral maxillary sinus augmentation with simultaneous implant placement at the Department of Oral and Maxillofacial Surgery, Dong-A University Hospital. The patients were classified into three groups: no bone graft (n=46), particulate bone graft (n=44), and rhBMP-2+ACS graft material (n=32) groups. Panoramic and cone-beam computed tomography images taken before and after surgery were used to evaluate the residual bone height (RBH), postoperative bone height (POBH), bone density, and type of bone formation at the apex of the implant (BT). Additionally, the implant survival rates and postoperative complications were analyzed.

Results: The 1-year implant survival rate was similar across all three groups, exceeding 95%. The particulate bone graft group demonstrated the best clinical outcomes in terms of POBH and bone density, as well as the most active bone formation at the BT. The incidence of complications did not differ significantly among the three groups.

Conclusion: Although particulate bone graft was effective for bone formation and space maintenance, no significant differences were observed in the implant survival rate or complications compared with the other methods. The sinus augmentation outcomes did not vary considerably regardless of the type of bone graft material used.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405773PMC
http://dx.doi.org/10.5125/jkaoms.2025.51.4.217DOI Listing

Publication Analysis

Top Keywords

bone graft
24
sinus augmentation
16
bone
16
particulate bone
16
lateral maxillary
12
maxillary sinus
12
bone formation
12
implant survival
12
recombinant human
8
human bone
8

Similar Publications

Purpose: Bone-patellar tendon-bone (BPTB) and Hamstring (HT) autografts are commonly used for anterior cruciate ligament reconstruction (ACLR). Concerns exist regarding postoperative anterior knee pain (AKP) and kneeling discomfort with BPTB grafts. However, many studies solely report the presence/absence of anterior knee pain, without assessing its clinical significance in terms of functional limitation or impact on quality of life.

View Article and Find Full Text PDF

Background/aims: Despite medical advances in recent decades, the mortality rate of advanced liver cirrhosis remains high. Although liver transplantation remains the most effective treatment, candidate selection is limited by donor availability and alcohol abstinence requirements. Bone marrow-derived mesenchymal stem cell (BM-MSC) transplantation has shown promise for the treatment of advanced cirrhosis.

View Article and Find Full Text PDF

Aim: Prickle planar cell polarity (PCP) protein 2 (Prickle2) encodes a homologue of Drosophila prickle and is involved in the non-canonical Wnt/PCP signalling pathway. However, its exact role in dentinogenesis remains unclear. Dentinogenesis, a key process in tooth morphogenesis, involves the patterned arrangement of odontoblasts and the formation of dentine matrix along the pulp cavity.

View Article and Find Full Text PDF

Adoptive cellular therapies in multiple myeloma.

Best Pract Res Clin Haematol

September 2025

Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania. Electronic address:

Plasma cell myeloma (multiple myeloma) is a blood cancer characterized by the clonal proliferation of plasma cells in the bone marrow. Treatment strategies evolve year by year, new drugs getting Food and Drug Administration (FDA)-approved each year. Chimeric antigen receptor (CAR) therapies are an advanced form of immunotherapy that engineer T cells to recognize and destroy cancer cells.

View Article and Find Full Text PDF

Adoptive cellular therapies in non-Hodgkin lymphomas.

Best Pract Res Clin Haematol

September 2025

Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania. Electronic address: c

Lymphomas are a group of malignant proliferations of B, T or NK-lymphoid cells at different stages of maturation. While they primarily occur in lymph nodes or lymphatic tissues, they can also involve bone marrow, blood, or other organs. Despite advances in treatment, many patients experience relapse, or develop refractory disease, prompting the development of new therapies.

View Article and Find Full Text PDF